Guidepoint Qsight offers institutional investors exclusive, near-real-time quantitative insights into the MedTech market. We deliver highly accurate and timely revenue projections and performance tracking from the industry’s largest datasets.
Empower Your Healthcare Investment Decisions with Our Advanced Data Analytics Suite
Built specifically for Investors and based on the latest and most robust healthcare data, Qsight Alpha consistently outperforms consensus, offering action-oriented insights into the performance and anticipated revenues of companies in the MedTech and Aesthetics sectors.
Explore Our Product Offerings Designed Specifically for Healthcare Investors
AlphaInstitutional investors gain unparalleled visibility into the performance and anticipated revenues of MedTech companies via proprietary, validated models built from transactional healthcare data.
FAQs: How We Can Help Healthcare Investors
Guidepoint Qsight provides investors with detailed data and insights, combining real-time transaction data and market projections to help assess company performances and enhance visibility in the MedTech sector.
Qsight ensures accurate and timely market projections by analyzing transactional data from U.S. healthcare facilities, offering precise insights into market dynamics to inform investment decisions.
Qsight tracks product-level performance at a variety of healthcare facility types, offering investors critical insights into product success, market adoption rates, and competitive positioning across Medical Device, HME/DME, and Aesthetics sectors.
Delivering More Than Just Data
Request a Demo Today
At Guidepoint Qsight, we empower decisions through unmatched, data-driven insights for the Aesthetics and MedTech industries. Send us your contact information today, and we’ll be in touch to discuss your concerns and overall needs. When it comes to data analytics, we’re the experts you can count on.
From Gen Z to GLP-1s: Trends Reshaping the Medical Aesthetics Industry
The competition between energy-based devices (EBD) and dermal fillers is intensifying in the U.S. Aesthetics market. Recent data from Qsight Market View reveals that EBD procedures are closing in on the spending dominance traditionally held by dermal fillers.
Outpace Aesthetic Market in 2025 with Qsight’s Prospector Tool
The competition between energy-based devices (EBD) and dermal fillers is intensifying in the U.S. Aesthetics market. Recent data from Qsight Market View reveals that EBD procedures are closing in on the spending dominance traditionally held by dermal fillers.
How Data is Transforming the Medical Aesthetics Market in 2025
The competition between energy-based devices (EBD) and dermal fillers is intensifying in the U.S. Aesthetics market. Recent data from Qsight Market View reveals that EBD procedures are closing in on the spending dominance traditionally held by dermal fillers.
Hit Your Sales Quota Fast with Qsight’s One-Call Prospector Tool
One of the biggest challenges in the medical aesthetics industry is meeting aggressive sales quotas—a hurdle that can lead to burnout, high turnover, and diminishing motivation. Enter Qsight Prospector: the industry’s first data-powered tool designed to empower sales teams with precision-targeted insights.